{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:40:16Z","timestamp":1790516416165,"version":"4.1.0"},"publisher-location":"Berlin, Heidelberg","reference-count":24,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"value":"9783642626760","type":"print"},{"value":"9783642563522","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2002]]},"DOI":"10.1007\/978-3-642-56352-2_1","type":"book-chapter","created":{"date-parts":[[2011,5,4]],"date-time":"2011-05-04T20:34:50Z","timestamp":1304541290000},"page":"1-8","source":"Crossref","is-referenced-by-count":37,"title":["Immunosurveillance, Immunodeficiency and Lymphoproliferations"],"prefix":"10.1007","author":[{"given":"Stephan H.","family":"Oertel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanno","family":"Riess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"1_CR1","first-page":"550","volume":"2","author":"P Ehrlich","year":"1957","unstructured":"Ehrlich P (1957) \u00dcber den jetzigen Stand der Karzinomforschung. In: The collected papers of Paul Ehrlich, vol 2, p 550","journal-title":"The collected papers of Paul Ehrlich"},{"key":"1_CR2","first-page":"2114","volume":"5","author":"NS Prang","year":"1997","unstructured":"Prang NS, Hornef MW, Jager M, et al (1997) Lytic replication of Epstein-Barr virus in the peripheral blood: analysis of viral gene expression in B lympho cytes during infectious mononucleosis and in the normal carrier state. Blood 5:2114\u20132116","journal-title":"Blood"},{"key":"1_CR3","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1056\/NEJM198407263110406","volume":"311","author":"FS Rosen","year":"1984","unstructured":"Rosen FS, Cooper MD, Wedgwood RJ (1984) The primary immunodeficiencie N Engl J Med 311:235\u2013242","journal-title":"N Engl J Med"},{"key":"1_CR4","first-page":"135","volume-title":"The non-Hodg-kin\u2019s lymphomas","author":"AH Filipovich","year":"1990","unstructured":"Filipovich AH, Shapiro R, Robison L, et al (1990) Lymphoproliferative disor-ders associated with immunodeficiency. In: Margrath IT (ed) The non-Hodg-kin\u2019s lymphomas. Edward Arnold, London, pp 135\u2013154"},{"key":"1_CR5","first-page":"35","volume":"1","author":"KSJ Elenitoba-Johnson","year":"1997","unstructured":"Elenitoba-Johnson KSJ, Jaffe ESI (1997) Lymphoproliferative disorders associated with congenital immunodeficiencies. Semin Diagn Pathol 1:35\u201347","journal-title":"Semin Diagn Pathol"},{"key":"1_CR6","first-page":"200","volume":"2","author":"D Knowles","year":"1999","unstructured":"Knowles DM (1999) Immunodeficiency-associated lymphoproliferative disorders Mod Pathol 2:200\u2013217","journal-title":"Immunodeficiency-associated lymphoproliferative disorders Mod Pathol"},{"key":"1_CR7","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1002\/(SICI)1096-911X(199912)33:6<536::AID-MPO3>3.0.CO;2-Z","volume":"6","author":"K Seidemann","year":"1999","unstructured":"Seidemann K, Tiemann M, Henze G, et al (1999) Therapy for non-Hodgkin lymphoma in children with primary immunodeficiency: analysis of 19 patients from the BFM trials. Med Pediatr Oncol 6:536\u2013544","journal-title":"Med Pediatr Oncol"},{"key":"1_CR8","first-page":"106","volume":"1","author":"I Penn","year":"1969","unstructured":"Penn I, Hammond W, Brettschneider L, Starzl TE (1969) Malignant lymphomas in transplantation patients. Transplant Proc 1:106\u2013112","journal-title":"Transplant Proc"},{"key":"1_CR9","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1056\/NEJM198910193211604","volume":"321","author":"L Young","year":"1989","unstructured":"Young L, Alfieri C, Hennessy K, et al (1989) Expression of Epstein-Barr virus trans format ion-associated genes in tissues of patients with EBV lymphoproliferative disease. N Engl J Med 321:1080\u20131085","journal-title":"N Engl J Med"},{"key":"1_CR10","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1182\/blood.V85.2.552.552","volume":"85","author":"DM Knowles","year":"1995","unstructured":"Knowles DM, Cesarmen E, Chadburn A, Frizzera G, et al (1995) Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders. Blood 85:552\u2013565","journal-title":"Blood"},{"key":"1_CR11","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S0140-6736(84)90994-2","volume":"1","author":"TE Starzl","year":"1984","unstructured":"Starzl TE, Nalesnik MA, Portier KA, et al (1984) Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet 1:583\u2013587","journal-title":"Lancet"},{"key":"1_CR12","doi-asserted-by":"crossref","unstructured":"Oertel SH, Ruhnke M, Anagnostopoulos I, et al (1999) Treatment of Epstein-Barr virus-induced post-transplant lymphoproliferative disorder (PT-LPD) with Foscarnet alone in an adult after simultaneous heart and renal translantation. Transplant, pp 765\u2013767","DOI":"10.1097\/00007890-199903150-00023"},{"key":"1_CR13","first-page":"577","volume":"11","author":"DV Faller","year":"2000","unstructured":"Faller DV, Hermine O, Small T, et al (2000) Phase I\/II trial of arginine butyrate to induce viral TK gene expression in Epstein-Barr virus associated lymphomas. Blood 11:577","journal-title":"Blood"},{"key":"1_CR14","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1097\/00007890-200002150-00021","volume":"3","author":"SH Oertel","year":"2000","unstructured":"Oertel SH, Anagnostopoulos I, Bechstein WO, et al (2000) Treatment of posttransplant lymphoproliferative disorder with the anti-CD20 monoclonal antibody rituximab alone in an adult after liver transplantation: a new drug in therapy of patients with PT-LPD after solid organ transplantation? Transplantation 3:430\u2013432","journal-title":"Transplantation"},{"key":"1_CR15","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1182\/blood.V92.5.1549","volume":"5","author":"CM Rooney","year":"1998","unstructured":"Rooney CM, Smith CA, Ng CY, et al (1998) Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogenic transplant recipients. Blood 5:1549\u20131555","journal-title":"Blood"},{"key":"1_CR16","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1182\/blood.V97.6.1590","volume":"6","author":"E Haddad","year":"2001","unstructured":"Haddad E, Pazesny S, Leblond V, et al (2001) Treatment of B-Iymphoproliferative disorders with a monoclonal anti-interleukin-6 antibody in 12 patients: a multicenter phase 1\u20132 clinical trial Blood 6:1590\u20131597","journal-title":"Blood"},{"key":"1_CR17","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1002\/1097-0142(19931101)72:9<2782::AID-CNCR2820720941>3.0.CO;2-H","volume":"72","author":"TJ Garrett","year":"1993","unstructured":"Garrett TJ, Chadburn A, Knowles DM, et al (1993) Post-transplant lymphoproliferative disorders treated with cyclophosphamide-doxorubicin-vincristine-prednisone chemotherapy. Cancer 72:2782\u20132785","journal-title":"Cancer"},{"key":"1_CR18","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1002\/(SICI)1097-0215(19971127)73:5<645::AID-IJC6>3.0.CO;2-X","volume":"73","author":"TR Cote","year":"1997","unstructured":"Cote TR, Biggar RJ, Rosenberg PS, et al (1997) Non-Hodgkin\u2019s lymphoma among people with AIDS: incidence, presentation and public health burden. Int I Cancer 73:645\u2013650","journal-title":"Int I Cancer"},{"key":"1_CR19","first-page":"67","volume":"14","author":"D Knowles","year":"1997","unstructured":"Knowles DM (1997) The molecular pathology of AIDS-related non-Hodgkin\u2019s lymphoma. Semin Diagn Pathol 14:67\u201382","journal-title":"Semin Diagn Pathol"},{"key":"1_CR20","unstructured":"Tirelli, M, Spina U, laeger E, Higra PL, Blanc AM, Liberati A, Benci JA (2001) Sparano. Infusional CDE with rituximab for the treatment of HIV-associated NHL: preliminary results of a phase I\/II study. Ree Results Cancer Res, p 159"},{"key":"1_CR21","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1007\/s002770050581","volume":"79","author":"U Schneider","year":"2000","unstructured":"Schneider U, Ruhnke M, Delecluse Hf, et al (2000) Regression of Epstein-Barr virus associated lymphoproliferative disorders in patients with acquired immunodeficiency syndrome during therapy with foscarnet. Ann Hematol 79:214\u2013216","journal-title":"Ann Hematol"},{"key":"1_CR22","first-page":"27","volume":"1","author":"O Kamel","year":"1997","unstructured":"Kamel OW (1997) Iatrogenic lymphoproliferative disorders in nontransplantational settings. Semin Diagn Pathol 1:27\u201334","journal-title":"Semin Diagn Pathol"},{"key":"1_CR23","first-page":"261","volume":"9","author":"RW Thomasen","year":"1996","unstructured":"Thomasen RW, Graig EE, Banks PM, et al (1996) Epstein-Barr virus and lymphoproliferation in methotrexate treated rheumatoid arthritis. Mod Pathol 9:261\u2013266","journal-title":"Mod Pathol"},{"key":"1_CR24","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1200\/JCO.1997.15.5.1803","volume":"5","author":"R Kurzrock","year":"1997","unstructured":"Kurzrock R, Strom SS, Estey E, et al (1997) Second cancer risk in hairy cell leukemia: analysis of 350 patients. J Clin Oncol 5:1803\u20131810","journal-title":"J Clin Oncol"}],"container-title":["Recent Results in Cancer Research","Immunosurveillance, Immunodeficiencies and Lymphoproliferations"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-642-56352-2_1.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T03:37:22Z","timestamp":1606189042000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-642-56352-2_1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002]]},"ISBN":["9783642626760","9783642563522"],"references-count":24,"URL":"https:\/\/doi.org\/10.1007\/978-3-642-56352-2_1","relation":{},"ISSN":["0080-0015"],"issn-type":[{"value":"0080-0015","type":"print"}],"subject":[],"published":{"date-parts":[[2002]]}}}